1994: FDA vaccine meeting. Dattwyler recommends using serial Western blots. This is apparently ignored.
In this transcript of the 1994 FDA LYMErix meeting, Raymond Dattwyler repeatedly argued against the intended proposal for an arthritic-knee-only case definition for Lyme disease.
Note that this took place in June 1994, which was before Dearborn, so the serodiagnosis business was still up in the air.
A couple of notable quotes: